Evidence map›Paper›PMID 40125023›Full record

ArticleNuclear medicine and molecular imaging2025

Assessing

André Salazar, Eduardo Paulino Júnior, Diego F Sánchez, Aízis Tatiane Santos Gonçalves, Renata Toscano Simões, Raul Silva-Filho, João V S Raimundo, Yuri V C Soares, Matheus L Marinho, Antonio L Cubilla and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Prevalence of the most common types of high-risk HPV and p16Postepy dermatologii i alergologii · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

André SalazarUrology Section, Mario Penna Institute, Belo Horizonte, Brazil.
Eduardo Paulino JúniorPathology and Forensic Department, Faculty of Medicine, Federal University Minas Gerais, Belo Horizonte, Brazil.
Diego F SánchezInstituto de Patologia e Investigacion, Asunción, Paraguay.
Aízis Tatiane Santos GonçalvesMolecular Biology Laboratory, Faculdade Santa Casa de Belo Horizonte (FSCBH), Belo Horizonte, Brazil.
Renata Toscano SimõesMolecular Biology Laboratory, Faculdade Santa Casa de Belo Horizonte (FSCBH), Belo Horizonte, Brazil.
Raul Silva-FilhoAnatomy and Imaging Department, Faculty of Medicine, Federal University Minas Gerais, Av Prof. Alfredo Balena, 190 Room 175, Belo Horizonte, 30130-100 Brazil.
João V S RaimundoFaculty of Medicine, Federal University Minas Gerais, Belo Horizonte, Brazil.
Yuri V C SoaresFaculty of Medicine, Federal University Minas Gerais, Belo Horizonte, Brazil.
Matheus L MarinhoFaculty of Medicine, Federal University Minas Gerais, Belo Horizonte, Brazil.
Antonio L CubillaInstituto de Patologia e Investigacion, Asunción, Paraguay.
Marcelo MamedeAnatomy and Imaging Department, Faculty of Medicine, Federal University Minas Gerais, Av Prof. Alfredo Balena, 190 Room 175, Belo Horizonte, 30130-100 Brazil.ORCID 0000-0001-5818-0954

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Penile Cancer is a rare and aggressive disease. Related to complex metabolic processes. Objective: This study investigates the effectiveness of Methods: Fifty-one patients were selected and underwent Results: Warty SCC showed the highest SUV value and significant differences in SUV Conclusions: The study highlights correlations between the uptake of Graphical Abstract: Supplementary Information: The online version contains supplementary material available at 10.1007/s13139-024-00877-y.

Indexed as

18F-FDGGLUT-1HK-IIHPVPenile NeoplasmProliferation biomarkers

Identifiers

PMID40125023
PMCPMC11923315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.